Meeting Communication Challenges Unique to CAR T-Cell Therapies

CAR T-cell therapies are one of the most important medical advances of the last decade, but there are many obstacles related to communication surrounding this treatment and getting it safely and effectively to all appropriate patients.

CAR T-cell therapies represent one of the most significant technical advances in the treatment of malignancies of the past decade. Given the complexity of CAR T-cell development, manufacture, testing and, ultimately, clinical use, it is important this technology has stringent regulations and guidance. In this article, we share how to address the communication challenges unique to this therapy.